Morphotek’s Busy Year Continues With NCI Collaboration On Prostate Cancer Antibody
This article was originally published in The Pink Sheet Daily
Executive Summary
Company hopes monoclonal antibody identified by NCI will demonstrate utility in multiple cancer types.